We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Boswellia

Boswellia carries a Grade B rating — moderate evidence.

Use extra caution — GI upset possible; caution with anticoagulants or anti inflammatory drugs. Details

Last reviewed: •2 sources citedReport a correctionProfile-wide ·B Moderate
Boswellia monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade B
Safety
GI upset possible; caution with anticoagulants or anti-inflammatory drugs.
Profile context
5-LOX, leukotriene pathways
Next steps

Continue reading

Quick stats

Evidence level
Moderate evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
5 LOX, Leukotriene Pathways
Avoid / review if
Known Allergy To Boswellia Or Other Burseraceae Family Plants

Safety

Safety & Cautions

GI upset possible; caution with anticoagulants or anti inflammatory drugs.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Stimulant-Like ProfileStimulant-like or activating caution language is present.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence Summary

Profile-wide ·B Moderate

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Leukotriene Reduction · 5 Lipoxygenase Inhibition

Research maturity: Established research — main contexts: 5 LOX · Leukotriene Pathways

Safety boundary: Safety note available — GI upset possible; caution with anticoagulants or anti inflammatory drugs.

This profile cites 2 human studies.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Moderate evidence

Boswellia has a moderate evidence rating.

General wellnessGeneral wellness
Citation density
2.5
Sources
5
Effects
2
Research recency
Mixed recency
Evidence Grade

Grade B: Moderate Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta analysis
Risk of Bias
Low
Consistency
Consistent
Strongest recorded design is a meta analysis, drawn from 6 recorded studies, 6 in people. No disagreement is recorded across them.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (5)4 human evidence sources · 2 human trials · ~162 participants across 1 human evidence source with reported N · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 4 human evidence sources; 2 are human trials. Across 1 human evidence source with a reported sample size, the approximate participant total is 162; overlapping publications may include some of the same people.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: A systematic review and network meta-analysis

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————Adds comparative pooled evidence for Boswellia, Curcuma, and combination formulations in knee OA.PubMed →

Efficacy evaluation of standardized Boswellia serrata extract (AflapinⓇ) in osteoarthritis: A systematic review and sub-group meta-analysis study

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————Pooled analyses showed improvements in pain and function; Aflapin subgroup showed larger effects in some analyses.PubMed →

Effect of a combination of C. longa and B. serrata extracts on hand osteoarthritis. Results of a double-blind, randomized, placebo-controlled, multicenter trial

PubMed · Osteoarthritis Cartilage · 2025

Background
Randomized controlled trial

Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.

n=162—————PubMed →

Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study

Background
Randomized controlled trial

Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.

—————WOMAC, pain, Lequesne, TNF, and hsCRP outcomes improved; SF-36 did not clearly improve.PubMed →

Scientific Rigour in the Assessment and Interpretation of Youth Cardiopulmonary Fitness: A Response to the Paper 'Normative Reference Values and International Comparisons for the 20-Metre Shuttle Run Test: Analysis of 69,960 Test Results among Chinese Children and Youth'

PubMed · J Sports Sci Med · 2020

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

——————PubMed →

How Boswellia Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Boswellia Works

How Boswellia WorksBoswellia acts on biological target pathways via anti inflammatory, leading to 5 lox.BoswelliaBiological TargetBiological pathwayAnti Inflammatory5 LoxObservable outcome
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
capsule or standardized extract
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Inflammatory Signaling Modulation
  • Leukotriene Reduction
  • 5 Lipoxygenase Inhibition

Guides that use Boswellia

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Boswellia evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Sourcing options

Boswellia product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Boswellia, verify the label for:

  • Standardized Extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
  • Third-Party Testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
  • Form Bioavailability: Ensure the form matches evidence-supported configurations (e.g. chelated bisglycinate/glycinate for magnesium, micronized monohydrate for creatine) for optimal onset and digestion tolerance.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?